|

Mid-day market update: Nasdaq drops 200 points; Soliton shares spike higher

Midway through trading Monday, the Dow traded up 0.86% to 35,078.24 while the NASDAQ fell 1.5% to 13,546.64. The S&P also rose, gaining 0.01% to 4,233.22.

The U.S. has the highest number of coronavirus cases and deaths in the world, reporting a total of 32,708,020 cases with around 581,750 deaths. India confirmed a total of at least 22,662,570 cases and 246,110 deaths, while Brazil reported over 15,184,790 COVID-19 cases with 422,340 deaths. In total, there were at least 158,399,250 cases of COVID-19 worldwide with more than 3,294,610 deaths, according to data compiled by Johns Hopkins University.

Leading and Lagging Sectors

Consumer staples shares rose 1.4% on Monday. Meanwhile, top gainers in the sector included 22nd Century Group, Inc. XXII 5.28%, up 5%, and BellRing Brands, Inc. BRBR 5.63%, up 4%.

In trading on Monday, information technology shares fell 1.3%.

Top Headline

Tyson Foods, Inc. TSN 1.77% reported better-than-expected results for its second quarter.

Tyson Foods reported quarterly earnings of $1.34 per share, beating analysts’ estimates of $1.12 per share. The company’s quarterly sales came in at $11.30 billion, versus expectations of $11.19 billion.

Tyson Foods said it expects chicken results to be lower in FY21 versus FY20.

Equities Trading UP

Soliton, Inc. SOLY 24.61% shares shot up 24% to $22.30 following a $22.60 per share buyout from AbbVie Inc. AbbVie’s Allergan Aesthetics unit will pay $550 million in cash to scoop up Soliton and Resonic, its sound-wave device that improves the appearance of cellulite.

Shares of Precipio, Inc. PRPO 37.77% got a boost, shooting 22% to $4.69 after the company announced it launched a new, four-hour Acute Myeloid Leukemia HemeScreen panel to specifically determine the genetics of this aggressive, acute form of leukemia.

Cue Biopharma, Inc. CUE 27.62% shares were also up, gaining 34% to $15.08 as the company reported confirmed partial response in ongoing Phase 1 monotherapy study of CUE-101 in late stage second line and beyond patients with HPV+ recurrent/metastatic head and neck cancer.

Equities Trading DOWN

The Trade Desk, Inc. TTD 20.77% shares tumbled 20% to $528.32 after the company reported it is facing a period of higher uncertainty in its business outlook. The company’s board also declared a ten-for-one split in the form of a stock dividend.

Shares of Village Farms International, Inc. VFF 19.17% were down 18% to $9.11 after the company swung to a loss in the first quarter.

Insmed Incorporated INSM 20.87% was down, falling 17% to $26.95 after the company reported a proposed concurrent public offerings of $250 million of common stock and $500 million convertible senior notes due 2028. Morgan Stanley maintained Insmed with an Overweight and lowered the price target from $58 to $56.

Commodities

In commodity news, oil traded down 0.7% to $64.48, while gold traded up 0.3% to $1,837.20.

Silver traded down 0.1% Monday to $27.46 while copper fell 0.9% to $4.7055.

Euro zone

European shares were mostly lower today. The eurozone’s STOXX 600 slipped 0.04%, the Spanish Ibex Index rose 0.77% and the German DAX 30 slipped 0.13%. Meanwhile, the London’s FTSE 100 fell 0.24%, French CAC 40 fell 0.16% and Italy’s FTSE MIB gained 0.59%.

The UK’s Halifax house price index increased 8.2% year-over-year in April.

Economics

Federal Reserve Bank of Chicago President Charles Evans is set to speak at 2:00 p.m. ET.

Author

Benzinga Team

Benzinga's news desk is a dynamic and innovative team that provides real-time, actionable articles that help readers navigate the market.

More from Benzinga Team
Share:

Markets move fast. We move first.

Orange Juice Newsletter brings you expert driven insights - not headlines. Every day on your inbox.

By subscribing you agree to our Terms and conditions.

Editor's Picks

EUR/USD retreats below 1.1750 on modest USD recovery

EUR/USD stays under modest bearish pressure and trades below 1.1750 on Friday. Although trading conditions remain thin following the New Year holiday and ahead of the weekend, the modest recovery seen in the US Dollar causes the pair to edge lower. The economic calendar will not feature any high-impact data releases.

GBP/USD struggles to gain traction, stabilizes above 1.3450

After testing 1.3400 on the last day of 2025, GBP/USD managed to stage a rebound. Nevertheless, the pair finds it difficult to gather momentum and moves sideways above 1.3450 as market participants remain in holiday mood.

Gold climbs toward $4,400 following deep correction

Gold reverses its direction and advances toward $4,400 after suffering heavy losses amid profit-taking before the New Year holiday. Growing expectations for a dovish Fed policy and persistent geopolitical risks seem to be helping XAU/USD stretch higher.

Cardano gains early New Year momentum, bulls target falling wedge breakout

Cardano kicks off the New Year on a positive note and is extending gains, trading above $0.36 at the time of writing on Friday. Improving on-chain and derivatives data point to growing bullish interest, while the technical outlook keeps an upside breakout in focus.

Economic outlook 2026-2027 in advanced countries: Solidity test

After a year marked by global economic resilience and ending on a note of optimism, 2026 looks promising and could be a year of solid economic performance. In our baseline scenario, we expect most of the supportive factors at work in 2025 to continue to play a role in 2026.

Crypto market outlook for 2026

Year 2025 was volatile, as crypto often is.  Among positive catalysts were favourable regulatory changes in the U.S., rise of Digital Asset Treasuries (DAT), adoption of AI and tokenization of Real-World-Assets (RWA).